Literature DB >> 18410837

Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium.

Vikhyat S Bebarta1, James A King, Marie McDonough.   

Abstract

Many consider proton pump inhibitors (PPIs) to be devoid of adverse effects; however, PPIs can cause serious adverse effects. We report on the case of an emergency department patient with omeprazole-induced hyponatremic delirium and rhabdomyolysis. Proton pump inhibitors are initially overlooked as a cause of hyponatremia and myopathy in the emergency department, as with our case. This case is also unique because no publication has reported on both hyponatremia and severe myopathy after PPI therapy. The patient recovered completely after cessation of omeprazole and initiation of intravenous saline hydration and desmopressin infusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410837     DOI: 10.1016/j.ajem.2007.08.026

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  11 in total

1.  Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

Authors:  Alice Capogrosso Sansone; Irma Convertino; Maria Teresa Galiulo; Stefano Salvadori; Stefania Pieroni; Tamara Knezevic; Stefania Mantarro; Alessandra Marino; Manfred Hauben; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

2.  Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.

Authors:  Santiago Vilar; Rave Harpaz; Herbert S Chase; Stefano Costanzi; Raul Rabadan; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2011-09-21       Impact factor: 4.497

Review 3.  Proton Pump Inhibitors and Risk of Rhabdomyolysis.

Authors:  Scott J Duncan; Colin W Howden
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

4.  Muscle cell membrane damage by very low serum sodium.

Authors:  Joye Varghese; Vallath Balakrishnan; Shine Sadasivan; Prem Nair; Venkadeswaran Anantha Narayanan
Journal:  Pan Afr Med J       Date:  2009-11-12

Review 5.  Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.

Authors:  Oren Cohen; Garrett Locketz; Alon Y Hershko; Alexander Gorshtein; Yair Levy
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

6.  Reduction in the rate of postoperative delirium by switching from famotidine to omeprazole in Japanese hepatectomized recipients.

Authors:  Miho Yamasaki; Yusa Fukuda; Aika Tanimoto; Miko Narahara; Yumi Kawaguchi; Hiromi Ushiroda; Saburo Fukuda; Teruo Murakami; Yorinobu Maeda
Journal:  J Pharm Health Care Sci       Date:  2019-05-07

7.  Comparison and analysis of delirium induced by histamine h(2) receptor antagonists and proton pump inhibitors in cancer patients.

Authors:  Shiro Fujii; Hitoshi Tanimukai; Yujiro Kashiwagi
Journal:  Case Rep Oncol       Date:  2012-07-31

8.  Adverse drug reactions in older patients: an Italian observational prospective hospital study.

Authors:  Anita Conforti; Davide Costantini; Francesca Zanetti; Ugo Moretti; Matteo Grezzana; Roberto Leone
Journal:  Drug Healthc Patient Saf       Date:  2012-07-17

9.  Rhabdomyolysis associated with single-dose intravenous esomeprazole administration: A case report.

Authors:  Dae-Hong Jeon; Yire Kim; Min Jeong Kim; Hyun Seop Cho; Eun Jin Bae; Se-Ho Chang; Dong Jun Park
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 10.  Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.

Authors:  Gloria Ortiz-Guerrero; Diana Amador-Muñoz; Carlos Alberto Calderón-Ospina; Daniel López-Fuentes; Mauricio Orlando Nava Mesa
Journal:  Neural Plast       Date:  2018-03-21       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.